Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.41 USD | +0.33% | +0.04% | -3.61% |
05:51pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
Filters
- Stock Market
- Equities
- NOVN Stock
- NVS Stock
- News Novartis AG
- Analyst Reco.